<SEC-DOCUMENT>0000950170-25-110227.txt : 20250819
<SEC-HEADER>0000950170-25-110227.hdr.sgml : 20250819
<ACCEPTANCE-DATETIME>20250819181420
ACCESSION NUMBER:		0000950170-25-110227
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250819
DATE AS OF CHANGE:		20250819

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Above Food Ingredients Inc.
		CENTRAL INDEX KEY:			0001979484
		STANDARD INDUSTRIAL CLASSIFICATION:	FOOD & KINDRED PRODUCTS [2000]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			A0
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-95199
		FILM NUMBER:		251233333

	BUSINESS ADDRESS:	
		STREET 1:		2305 VICTORIA AVENUE #001
		CITY:			REGINA, SASKATCHEWAN
		STATE:			A0
		ZIP:			S4P 0S7
		BUSINESS PHONE:		(306) 779-2268

	MAIL ADDRESS:	
		STREET 1:		2305 VICTORIA AVENUE #001
		CITY:			REGINA, SASKATCHEWAN
		STATE:			A0
		ZIP:			S4P 0S7

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arcadia Biosciences, Inc.
		CENTRAL INDEX KEY:			0001469443
		STANDARD INDUSTRIAL CLASSIFICATION:	CRUDE PETROLEUM & NATURAL GAS [1311]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				810571538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		202 COUSTEAU PLACE
		STREET 2:		SUITE 105
		CITY:			DAVIS
		STATE:			X1
		ZIP:			95618
		BUSINESS PHONE:		530-756-7077

	MAIL ADDRESS:	
		STREET 1:		202 COUSTEAU PLACE
		STREET 2:		SUITE 105
		CITY:			DAVIS
		STATE:			CA
		ZIP:			95618
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001469443</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>08/12/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001979484</issuerCik>
        <issuerName>Above Food Ingredients Inc.</issuerName>
        <issuerCusip>00373V100</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">2305 Victoria Avenue, Suite 001</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Regina, Saskatchewan</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">Z4</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">S4P 0S7</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Arcadia Biosciences, Inc.</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2738574</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>2738574</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2738574</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.08</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Above Food Ingredients Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>2305 Victoria Avenue, Suite 001 Regina, Saskatchewan S4P 0S7 Canada</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Arcadia Biosciences, Inc., a Delaware corporation ("Arcadia")</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>5950 Sherry Lane, Suite 215, Dallas, TX 75225</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Delaware</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>2,738,574 shares of common stock</amountBeneficiallyOwned>
        <classPercent>5.08%. The percent of class is based on the sum of (i) 51,191,848 shares of common stock outstanding as of May 2, 2025, as reported by Issuer on its Form 6-K filed with the Securities and Exchange Commission on May 23, 2025, plus (ii) the 2,738,574 shares of common stock owned by Arcadia.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>2,738,574</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>2,738,574</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Arcadia Biosciences, Inc.</reportingPersonName>
      <signatureDetails>
        <signature>Thomas J. Schaefer</signature>
        <title>Thomas J. Schaefer, CEO</title>
        <date>08/19/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
